| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MRSN (MRSN) has 13 insiders with recent SEC Form 4 filings, including 6 buys and 4 sells. MRSN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2020 | Mott David M88 | Director | Buy | 538,599 | $5.59 | $3,010,768.41 | New | |
| Aug 28, 2019 | New Enterprise Associates 14, L.P. | 10% Owner | Sell | 1,211 | $2.91 | $3,524.01 | - | |
| Mar 5, 2019 | Mott David M88 | Director, 10% Owner | Buy | 3,750,000 | $4.00 | $15,000,000.00 | +46.1% | |
| Mar 5, 2019 | New Enterprise Associates 14, L.P. | 10% Owner | Buy | 3,750,000 | $4.00 | $15,000,000.00 | +46.1% | |
| Sep 24, 2018 | Lowinger Timothy B | Chief Scientific Officer | Sale+OE | 3,500 | $11.63 | $40,705.00 | -21.9% | |
| Aug 27, 2018 | Lowinger Timothy B | Chief Scientific Officer | Sale+OE | 3,500 | $13.15 | $46,025.00 | -21.9% | |
| Jul 23, 2018 | Lowinger Timothy B | Chief Scientific Officer | Sell | 3,500 | $11.06 | $38,710.00 | -21.9% | |
| Jul 3, 2017 | Viswanathan Ravi | 10% Owner | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +14.0% | |
| Jul 3, 2017 | Sonsini Peter W. | 10% Owner | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +14.0% | |
| Jul 3, 2017 | Sandell Scott D55 | 10% Owner | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +14.0% |